BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/29/2014 11:57:00 AM | Browse: 1323 | Download: 1328
 |
Received |
|
2013-10-26 12:41 |
|
Peer-Review Started |
|
2013-10-27 12:50 |
|
To Make the First Decision |
|
2013-12-16 17:49 |
|
Return for Revision |
|
2013-12-17 16:28 |
|
Revised |
|
2014-01-11 05:53 |
|
Second Decision |
|
2014-05-29 20:18 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2014-05-29 20:51 |
|
Articles in Press |
|
2014-05-29 21:03 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2014-08-11 12:27 |
|
Publish the Manuscript Online |
|
2014-08-29 11:57 |
| Category |
Oncology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Therapeutic options for the management of pancreatic cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Maria L Rossi, Azeem A Rehman and Christopher S Gondi |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| William E McElroy Foundation |
to Gondi CS |
| Carrie M. Craig Medical Student Summer Research Fellowship Program sponsored by the University of Illinois College of Medicine at Peoria |
to Rossi ML |
|
| Corresponding Author |
Correspondence to: Christopher S Gondi, PhD, Assistant Professor, Department of Medicine, University of Illinois College of Medicine-Peoria, Box 1649, Peoria, IL 61656-1649, United States. gondi@uic.edu |
| Key Words |
Pancreatic cancer; Pancreatic cancer stem cells; Microenvironment; Surgical resection; Neoadjuvant therapy; Adjuvant therapy; Chemotherapy; Radiation; Personalized therapy |
| Core Tip |
Pancreatic ductal adenocarcinoma has challenged researchers for decades. It remains one of the most deadly cancers due to the complex molecular and genetic makeup of its cancer cells and their surrounding microenvironment. In addition, there are no valid screening tests available to detect pancreatic cancer in its early stages. Yet, as knowledge of this cancer has evolved over time, so have novel methods for treating it. Researchers have a deeper understanding of pancreatic cancer now than ever before. The future holds much promise for new breakthroughs that will significantly improve patient outcomes. |
| Publish Date |
2014-08-29 11:57 |
| Citation |
Rossi ML, Rehman AA, Gondi CS. Therapeutic options for the management of pancreatic cancer. World J Gastroenterol 2014; 20(32): 11142-11159 |
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i32/11142.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i32.11142 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
